Amgen Shines Amid Healthcare Sector's Strong Performance

The healthcare sector has been performing well lately, with stocks returning 23.2% over the past six months and outpacing the S&P 500 by 11.5 percentage points.

However, investors should be cautious due to the heavily regulated nature of the industry, which can negatively impact businesses if rules change.

Among healthcare companies, Amgen stands out with its strong revenue base and free cash flow machine status, allowing it to invest in growth initiatives or return capital to shareholders.

Its Return on Invested Capital (ROIC) is 17.3%, demonstrating management's expertise in identifying profitable investments.